Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4, Open-label Trial to Assess the Safety, Tolerability and Immunogenicity of Prevenar in Older Infants and Young Children in China Who Are Naive to Previous Pneumococcal Vaccination.

NCT01193582 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01193582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01193582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4, Open-label Trial to Assess the Safety, Tolerability and Immunogenicity of Prevenar in Older Infants and Young Children in China Who Are Naive to Previous Pneumococcal Vaccination.
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2010
Completion date
September 30, 2012
Enrollment
505 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

pneumococcal infections